Testosterone’s capacity to aromatize to E2 and activate ERα may serve as the mechanism for testosterone-mediated fat loss. Moreover, ERαKO resulted in significantly increased adipocyte size and count in epididymal and perirenal adipose depots at PND180, altogether highlighting the importance of E2 and ERα in maintaining sex-specific adipose development. Aromatase knockout (ArKO) inhibits endogenous E2 production and results in an obese phenotype in both male and female mice .
Therefore, the benefits of testosterone replacement therapy on major depressive disorder in men with clinically defined hypogonadism remains uncertain and will hopefully be elucidated by the TRAVERSE Trial and other ongoing research. Increasing synaptic levels of serotonin with selective serotonin reuptake in inhibitors contributes to antidepressant responses in depression . Deficient serotonergic neurotransmission and reduced serotonin 5-HT1A and 5-HT1B receptor signaling has an important role in the pathophysiology of major depressive disorder and form the basis of the serotonin hypothesis of depression .
Testosterone has been detected at variably higher and lower levels among men of various nations and from various backgrounds, explanations for the causes of this have been relatively diverse. Immunofluorescence assays exhibit considerable variability in quantifying testosterone concentrations in blood samples due to the cross-reaction of structurally similar steroids, leading to overestimating the results. In measurements of testosterone in blood samples, different assay techniques can yield different results.
About half of studies have found a relationship and about half, no relationship. have been undertaken on the relationship between more general aggressive behavior, and feelings, and testosterone. On the other hand, elevated testosterone in men may increase their generosity, primarily to attract a potential mate. Testosterone levels play a major role in risk-taking during financial decisions. Men who produce less testosterone are more likely to be in a relationship or married, and men who produce more testosterone are more likely to divorce. However, the testosterone changes observed do not seem to be maintained as relationships develop over time. There has been speculation that these changes in testosterone result in the temporary reduction of differences in behavior between the sexes.|As the CAG repeat length increases, the association between testosterone and Vitality is lost. The nature of the interaction is such that when the CAG repeat length is short, testosterone has a significant negative association with the Vitality subscale. Results from the mixed effects models, both with and without the interaction effect, are presented in Table 2. After accounting for missing data among our covariates, data were available for 676 participants in total, 103 with low testosterone, 484 with normal testosterone, and 89 who were classified as having high testosterone. Characteristics of the VETSA subsample with testosterone data, as well as differences among the low, normal and high testosterone groups are presented in Table 1.|The agonist or antagonist activity of the ligand is often examined in vitro using cotransfection assays in which the recombinant AR and a hormone-dependent reporter gene are transiently expressed in a receptor-negative cell line. Free testosterone is considered the most "biologically active" form, so the circulating level of sex hormone-binding globulin also affects the biologic effects of testosterone. Animal studies73 showed that, after intravenous administration, radiolabeled androgens demonstrate higher tissue uptake in androgen target tissues, like the prostate where AR is highly expressed. Although there is no direct evidence to suggest that testosterone causes the disease, early-stage prostate cancer is clearly dependent on androgen.|Overall, the specific role of neuronal AR on body composition and skeletal muscle morphology remains unknown, but these works demonstrate that AR expression in specific brain and nervous tissue regions could regulate adiposity and fiber-type specific mass potentially through changes to physical activity motivation. Overall, AR expression in SCs may play a minor role in maintaining age-specific activity and muscle strength outcomes, with limited impacts on lean or fat body composition in males. In young adult males, the average testosterone levels range from 7–35 nmol/L , with most studies pointing to a steady 1–2% decline of bioavailable testosterone per year beyond 30 years of age 53–55, while a few studies report a minimal decline in circulating testosterone between 35- and 65-years of age 56–58.|In contrast to the TBM deficits in HSAAR male mice, TBM was equivalent between WT and HSAAR male rats at 8- to 10-weeks of age and 4- to 10-weeks of age . In 2009, Niel and colleagues used a previously generated skeletal muscle-specific AR overexpression vector to generate the transgenic HSAAR and Tfm/HSAAR cross in Sprague Dawley rats. The study observed that both HSAAR lines had reduced myofibril width and increased interfibrillar mitochondrial density in EDL, while HSAAR males from only L78 presented a fiber-type transition from fast-oxidative (FO) to fast-oxidative-glycolytic (FOG) and an increase in ETC complex activity in TA . This work also detailed the first generation of a mouse Tfm/HSAAR transgenic cross, which produced viable offspring with non-functional AR in all tissues except for that of skeletal muscle, where functional AR overexpression remained. However, the generation of novel transgenic mice with excessive CAG repeats in the polyglutamine tract of AR to model Kennedy’s Disease highlighted the involvement of mutated AR in androgen-dependent muscle and motoneuron pathology 34, 250. Although this study did not measure the response of neuronal AR deficiency on skeletal muscle phenotypic or functional outcomes, the data supported a role in neuronal AR for mitigating an obesogenic phenotype in an age-dependent manner. The involvement of the motor neuron and its innervated muscle fibers is indispensable in positive or negative stressor-induced changes to muscle mass, fiber hypertrophy, fiber-type transition, and strength.|Not only that, it decreases muscle breakdown and freezes the blocked androgen receptors in the body. Shoulders, the upper and middle chest, and neck have more androgen receptors than your leg muscles or most body parts. Synthetic testosterone takes the responsibility to bulk up your muscle strength and power by activating the androgen receptors. These hormones can do a little to the body if the AR or androgen receptors are not activated. But to use the hormone in their favor, the body needs to activate androgen receptors. Studies on rodents have shown that chronic low-dose caffeine intake can increase testosterone levels, DHT levels, and androgen receptor (AR) expression. …And as an icing to the cake, there’s the fact that levadopa acts as a co-activator protein to the androgen receptors, effectively enhancing their activity in in-vitro studies (study, study).}
While androgen hormones such as testosterone and DHT are of extreme importance for every man’s health, to get the most out of them it is necessary to increase the density and sensitivity of androgen receptors. A study from the Medicine and Science in Sports and Exercise showed that 18 untrained men who were assigned to resistance training experienced an increase in androgen receptor and protein as well as higher testosterone levels. Therefore, to enhance effects of these hormones you should work to increase density and sensitivity of androgen receptors. Likewise, the development of selective AR modulators (SARMs) that target the specific actions of the AR within a specific cell/tissue type will be pertinent to large groups of patients who cannot be administered testosterone due to potential side-effects, including women, ageing men and prostate cancer patients undergoing ADT.
Quantification of AR-positivity was significantly higher in myonuclei and fibroblasts of post-natal day (PND) 60–90 male LA compared to EDL 7, 85. Free testosterone is lipid soluble and upon crossing through the plasma membrane, heat shock protein (Hsp70/90) inhibition of AR is removed, and testosterone or DHT are free to bind to AR 64, 65. Peripheral conversion of DHEA to testosterone can be seen in the brain, liver, breast, blood cells, skin, adipose, adrenal glands, gonads, and accessory sex organs. The adrenal glands play a significant role in androgen production (alongside the ovaries) in women, where dehydroepiandrosterone (DHEA), as well as small amounts of cortisol and E2, are secreted from the zona reticularis of the adrenal cortex 45, 46.
Membrane androgen receptor signaling via non-canonical cascades may be especially important in brain neurons and relevant to antidepressant actions of testosterone by promote cell survival, neurogenesis, synaptic density, and synaptic remodeling in the hippocampus, prefrontal cortex, and other brain regions . The non-canonical actions of membrane androgen receptors may be coordinated with the canonical actions of androgen receptors in the nucleus. In addition to the slower genomic actions of the cytosolic AR after translocating to the nucleus, androgen receptors expressed on the cell surface have rapid, non-genomic actions by signaling via downstream calcium, Akt, MAPK-ERK kinase, and protein kinase pathways (Fig. 1), which can regulate synaptic plasticity and have other brain actions 88, 94, 95. In the central nervous system, androgen receptors are highly expressed in the arcuate nucleus and other medial basal region of the hypothalamus, the bed nucleus of the stria terminalis and amygdala in limbic pathway, the hippocampus, and the temporal lobe, which are brain regions regulating mood and cognitive function 91, 92. Testosterone binds to the androgen receptor with a low nanomolar affinity, while the stronger biological action of DHT is mediated by its two-fold higher affinity and five-fold lower rate of dissociation from the AR compared to testosterone. In 2003, a small RCT study reported that the mean Hamilton score (21.8) in younger men (mean age 46.9 years) with hypogonadism and major depressive disorder refractory to antidepressant medications decreased by ~ 60% when their total testosterone levels were increased from 293 to 789 ng/dl (10.16–27.36 nmol/L SI units) by TRT compared to placebo treatment . Three early interventional studies of TRT using testosterone gel or intramuscular testosterone undecanoate in men with hypogonadism based on mean total testosterone levels ranging from 230 to 300 ng/dl (7.97–10.40 SI units) reported a significant reduction in depressive symptoms 80–82.

性別: 女性

SNSリンク